MUROMONAB-CD3 for Transplant rejection: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where MUROMONAB-CD3 was used for Transplant rejection.
Most Reported Side Effects for MUROMONAB-CD3
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Post transplant lymphoproliferative disorder | 22 | 19.3% | 3 | 14 |
| Infection | 16 | 14.0% | 6 | 3 |
| Cytomegalovirus infection | 13 | 11.4% | 5 | 4 |
| Cytomegalovirus oesophagitis | 10 | 8.8% | 1 | 0 |
| Drug resistance | 10 | 8.8% | 1 | 0 |
| Duodenitis | 10 | 8.8% | 1 | 1 |
| Gastritis | 10 | 8.8% | 1 | 1 |
| Weight decreased | 10 | 8.8% | 1 | 0 |
| Chest pain | 9 | 7.9% | 1 | 0 |
| Cytomegalovirus chorioretinitis | 9 | 7.9% | 0 | 0 |
| Cytomegalovirus infection reactivation | 9 | 7.9% | 1 | 0 |
| Encephalitis | 9 | 7.9% | 1 | 0 |
| Gastric fistula | 9 | 7.9% | 1 | 0 |
| Gastric ulcer | 9 | 7.9% | 1 | 0 |
| Gastrointestinal ulcer | 9 | 7.9% | 1 | 0 |
Other Indications for MUROMONAB-CD3
Immunosuppressant drug therapy (38)
Prophylaxis against transplant rejection (20)
Prophylaxis against graft versus host disease (13)
Immunosuppression (12)
Product used for unknown indication (11)
Bone marrow conditioning regimen (8)
Allogenic stem cell transplantation (5)
Other Drugs Used for Transplant rejection
METHYLPREDNISOLONE (968)
RITUXIMAB (615)
TACROLIMUS (477)
HUMAN IMMUNOGLOBULIN G (327)
PREDNISONE (300)
MYCOPHENOLATE MOFETIL (297)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (273)
ECULIZUMAB (176)
THYMOCYTE IMMUNE GLOBULIN NOS (173)
BORTEZOMIB (145)